Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation.

Introduction: In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation. Methods: The 2016–2020 National Inpatient Sample (NIS...

Descripción completa

Detalles Bibliográficos
Publicado en:Pacing & Clinical Electrophysiology Vol. 47; no. 10; pp. 1394 - 1404
Autores principales: Ahmed, Raheel, Jamil, Yumna, Ramphul, Kamleshun, Mactaggart, Sebastian, Bilal, Maham, Singh Dulay, Mansimran, Shi, Rui, Azzu, Alessia, Okafor, Joseph, Memon, Rahat A, Sakthivel, Hemamalini, Khattar, Rajdeep, Wells, Athol Umfrey, Baksi, John Arun, Wechalekar, Kshama, Kouranos, Vasilis, Chahal, Anwar, Sharma, Rakesh
Formato: diagnostic images research tables/charts Journal Article
Publicado: Wiley-Blackwell Oct2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=180170748&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 180170748
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01478389
        4F8
      jtl: Pacing & Clinical Electrophysiology
      issn: 01478389
      maglogo: Y
    pubinfo:
      dt: Oct2024
      vid: 47
      iid: 10
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        180170748
        178676301
        180170748
        180170748
        10.1111/pace.15051
        180170748
      ppf: 1394
      ppct: 10
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation.
      aug:
        au:
          Ahmed, Raheel
          Jamil, Yumna
          Ramphul, Kamleshun
          Mactaggart, Sebastian
          Bilal, Maham
          Singh Dulay, Mansimran
          Shi, Rui
          Azzu, Alessia
          Okafor, Joseph
          Memon, Rahat A
          Sakthivel, Hemamalini
          Khattar, Rajdeep
          Wells, Athol Umfrey
          Baksi, John Arun
          Wechalekar, Kshama
          Kouranos, Vasilis
          Chahal, Anwar
          Sharma, Rakesh
        affil: Royal Brompton Hospital, part of Guy's and St Thomas' NHS Foundation Trust, London, UK
      sug:
        subj:
          Sarcoidosis Therapy
          Sarcoidosis Epidemiology
          Defibrillators, Implantable Adverse Effects
          Sex Factors
          Human
          Male
          Female
          Middle Age
          Aged
          Inpatients
          United States
          Retrospective Design
          Record Review
          Death, Sudden, Cardiac Prevention and Control
          Death, Sudden, Cardiac Epidemiology
          Myocardial Diseases Therapy
          Cardiac Patients
          Hospitalization Statistics and Numerical Data
          Treatment Outcomes
          Atrial Fibrillation Epidemiology
          Major Adverse Cardiac Events Risk Factors
          Descriptive Statistics
          Comparative Studies
          Odds Ratio
          Confidence Intervals
          Hospital Mortality
          Prevalence
          Incidence
          Comorbidity
          Questionnaires
          Kidney Failure, Acute Epidemiology
          Length of Stay
          Health Facility Charges
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Introduction: In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation. Methods: The 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs. Results: Among 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p <.01), had higher rates of diabetes (31.7% vs. 21.6%, p <.01) and chronic kidney disease (CKD) (16.8% vs. 7.8%, p <.01) but lower prevalence of atrial fibrillation (AF) (11.9% vs. 23.5%, p <.01), sick sinus syndrome (4.0% vs. 7.8%, p =.024), ventricular fibrillation (VF) (9.9% vs. 15.7%, p =.02), and black ancestry (31.9% vs. 58.0%, p <.01). Unadjusted major adverse cardiovascular events (MACE), defined as a composite of in‐hospital death, myocardial infarction (MI), and ischemic stroke, was higher in females (11.8% vs. 6.9%, p =.024), but when adjusted for age and tCharlson Comorbidity Index (CCI), females demonstrated significantly lower odds of experiencing MACE (aOR: 0.048, 95% CI: 0.006–0.395, p =.005). Incidence of acute kidney injury (AKI) post‐ICD was significantly lower in females (15.7% vs. 23.8%, p =.01) as was the adjusted odds (aOR: 0.282, 95% CI: 0.146–0.546, p <.01). There was comparable mean length of stay and hospital charges. Conclusion: ICD utilization in CS patients is more common among males, who have a higher prevalence of diabetes and CKD but a lower prevalence of AF, sick sinus syndrome, and VF. Adjusted MACE and AKI were significantly lower in females.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N